Merck's (NYSE:MRK) Soft Earnings Don't Show The Whole Picture
Merck & Co., Inc. (NYSE:MRK) reported soft earnings, but Simply Wall St's analysis suggests that the underlying business foundations are strong. The l...
Merck & Co., Inc. (NYSE:MRK) reported soft earnings, but Simply Wall St's analysis suggests that the underlying business foundations are strong. The l...
Neutral
Securian Asset Management Inc. recently reduced its stake in Merck & Co., Inc. (NYSE:MRK) by 44.1%, now holding 67,491 shares valued at $7.10 million....
Neutral
NewEdge Wealth LLC significantly increased its stake in Merck & Co., Inc. by 37.8% in Q4, now holding 88,597 shares valued at $9.33 million. Merck's r...
Neutral
Osprey Private Wealth LLC significantly increased its stake in Merck & Co., Inc. by 92.1% in the fourth quarter, now holding 29,240 shares valued at $...
Neutral
Bryn Mawr Trust Advisors LLC slightly reduced its stake in Merck & Co., Inc. by 5%, but still holds 230,574 shares valued at $24.27 million, making it...
Neutral
Chesapeake Capital Corp IL acquired a new stake in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) in the 4th quarter, according to the company i...
Neutral
Ethic Inc. increased its position in Merck & Co., Inc. (NYSE:MRK – Free Report) by 9.3% in the 4th quarter, according to its most recent disclosure wi...
Bullish
Merck & Co., Inc. (NYSE:MRK) has received a consensus "Moderate Buy" rating from 19 brokerages, with an average 1-year price target of $128.18. Recent...
Neutral
Crossmark Global Holdings Inc. has reduced its stake in Merck & Co., Inc. by 7.6% in the fourth quarter, now holding 235,906 shares valued at approxim...
Neutral
Merck & Co., Inc. has reported strong quarterly results driven by its oncology and vaccine segments, particularly Keytruda and Gardasil, impressing in...
Bullish
Merck & Co., Inc. has released its latest quarterly results, showing robust growth in oncology and vaccine sales, with revenue reaching approximately ...
Bullish
Generali Asset Management SPA SGR reduced its stake in Merck & Co., Inc. (NYSE:MRK) by 9.5% during the fourth quarter, selling 32,367 shares and leavi...
Bullish
Lmcg Investments LLC increased its stake in Merck & Co., Inc. by 14.8% during the fourth quarter, bringing their total holdings to 142,525 shares valu...
Bullish
Bokf Na reduced its stake in Merck & Co., Inc. by 18.2%, selling 28,321 shares and retaining 127,249 shares valued at approximately $13.39 million. Th...
Neutral
Stack Financial Management Inc lowered its stake in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) by 2.7% in the fourth quarter, according to i...
Neutral
Christine Messmer PC has acquired a new stake of 17,072 shares in Merck & Co., Inc. during Q4, valued at $1.797 million. This new holding represents a...
Neutral
Intact Investment Management Inc. reduced its stake in Merck & Co., Inc. (NYSE:MRK) by 8.8% in the fourth quarter, selling 17,600 shares. Other instit...
Bullish
FSA Advisors Inc. recently acquired a new position in Merck & Co., Inc. (NYSE:MRK), purchasing 11,280 shares valued at approximately $1.187 million in...
Neutral
CX Institutional increased its stake in Merck & Co., Inc. by 10.1% in the fourth quarter, purchasing an additional 9,768 shares, bringing its total ho...
Neutral
Benjamin Edwards Inc. reduced its stake in Merck & Co., Inc. by 4.3% in the fourth quarter of the prior year, selling over 21,000 shares. Despite this...